Acceleration of purine synthesis in mouse liver by glycogenolytic hormones

Pnina Boer, Rivka Mamet, Oded Sperling*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Administration (ip) into fed mice of glucagon, epinephrine, vasopressin, oxytocin, angiotensin II, and dibutyryl cyclic AMP (dbcAMP) resulted in a rapid (within 2.5 to 15 min) elevation of PRPP content (two- to threefold) and in acceleration of the rate of de novo purine synthesis (twofold). Inhibition of the epinephrine-stimulated glycogenolysis by 2,5-anhydromannitol diminished markedly the acceleration effect of the hormone on the rate of purine synthesis. Administration of the hormones caused a rapid rise in the liver content of glucose 6-phosphate (G6P) by 15-70% but did not increase the ribose 5-phosphate (R5P) content. Liver ATP content was not affected. The hormones did not cause direct activation of PRPP synthetase, as gauged by the specific activity of the enzyme, its Km for substrates R5P and ATP, and its sensitivity to inhibition by ADP and GDP. The hormones did not increase the liver content of the enzyme activators Pi and Mg2+. The results suggest that the glycogenolytic hormones accelerate purine synthesis by a metabolic mechanism associated with the enhancement of glycogenolysis. PRPP synthesis is probably enhanced by the glycogenolysis-induced alterations in the cellular content of some metabolites other than R5P.

Original languageEnglish
Pages (from-to)185-195
Number of pages11
JournalBiochemical Medicine and Metabolic Biology
Issue number2
StatePublished - Oct 1991


Dive into the research topics of 'Acceleration of purine synthesis in mouse liver by glycogenolytic hormones'. Together they form a unique fingerprint.

Cite this